|
Market Closed -
Nasdaq
01:30:00 26/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.830 USD | +0.55% |
|
-3.17% | +0.55% |
Evolution of the Average Target: Alzamend Neuro, Inc.
Evolution of the Target Price: Alzamend Neuro, Inc.
Changes in Analyst Recommendations: Alzamend Neuro, Inc.
a3c8d49b.J5LuzKajNMp97kg1qdZ9XWEu6ppeOT3yY-vqaO4o2g0.EPmKqu7NW5kFgGV7w4MPFQlDs6wud0nDEtugIK1DnnRpy9-665VZjyKpfA~3871173b4125b27110f7188e7276e1ea
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +1,320.77% | |||
| +20.9% | |||||
| +2.8% | |||||
| +23.88% | |||||
| +19.94% | |||||
| +50.95% | |||||
| -5.99% | |||||
| -6.61% | |||||
| +38.36% | |||||
| -19.36% | |||||
| Average | +144.56% | |||||
| Weighted average by Cap. | +17.01% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.830USD
Average target price
26.00USD
Spread / Average Target
+1,320.77%
High Price Target
26.00USD
Spread / Highest target
+1,320.77%
Low Price Target
26.00USD
Spread / Lowest Target
+1,320.77%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ALZN Stock
- Consensus Alzamend Neuro, Inc.
Select your edition
All financial news and data tailored to specific country editions
